This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization US

Early Registration Savings Deadline Expires In

  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event
September 27-30, 2022Boston Convention and Exhibition Center

John Mikitsh
Engineer, Process and Product Development at Century Therapeutics, LLC


John Mikitsh has been working in the CGT space for the past 5 years. A biochemist and chemical engineer by training, his background primarily involves early stage process development and technology transfer. After leading development of suspension lentivirus and adeno-associated virus platforms at WuXi Advanced Therapies, he joined Century Therapeutics in 2019. John now leads a small team in the process and product development group. The team is responsible for scaling up iPSC derived manufacturing processes, design of Century’s GMP processing space, and tech transfer.

Agenda Sessions

  • iPSC Derived NK Cultures in Suspension Systems